Risk of Nephrogenic Systemic Fibrosis from Gadoxetic Acid in Patients with Severe Kidney Disease

Radiology. 2020 Dec;297(3):563-564. doi: 10.1148/radiol.2020203644. Epub 2020 Sep 29.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Gadolinium DTPA / adverse effects
  • Humans
  • Kidney Diseases* / chemically induced
  • Nephrogenic Fibrosing Dermopathy* / chemically induced
  • Patients

Substances

  • gadolinium ethoxybenzyl DTPA
  • Gadolinium DTPA